Skip to main content

Table 1 Clinical characteristics of participants at baseline

From: Increase of blood-brain barrier leakage is related to cognitive decline in vascular mild cognitive impairment

  vMCI group N = 26 Control
N = 21
P
Male, N (%) 12(46.2%) 8(38.1%) 0.583
Age, years 71.04 ± 8.99 66.67 ± 9.19 0.108
Education, years 11.58 ± 3.18 11.62 ± 3. 49 0.966
Vascular risk factors
 BMI, kg/m2 26.02 ± 4.21 25.72 ± 2.42 0.774
 Hypertension, N(%) 26(100.0%) 11(52.4%) <0.001
 Current Smoking, N(%) 4(15.4%) 3(14.3%) 0.623
 T2DM, N(%) 4(15.4%) 3(14.3%) 0.623
 Hyperlipidemia, N(%) 20(76.9%) 11(52.4%) 0.081
MTA scale
 Right(median (range)) 0(0,1) 0(0,1) 0.085
 Left(median (range)) 0(0,1) 0(0,1) 0.085
MoCA 23.04 ± 2.32 28.00 ± 1.22 <0.001
MMSE 26.31 ± 1.12 29.24 ± 0.70 <0.001
  1. Data are presented as mean ± SD, or counts (%)
  2. Abbreviations: N number of persons, vMCI vascular mild cognitive impairment, BMI body mass index, T2DM type 2 diabetes mellitus, MTA medial temporal lobe atrophy, MoCA Montreal Cognitive Assessment, MMSE mini-mental state examination